Shamama Javed | Drug Delivery Systems | Pharmaceutical Excellence Award

Published on by Top Pharmaceutical

Pharmaceutical Excellence Award

Shamama Javed – Jazan University, Saudi Arabia

Shamama Javed
Affiliation Jazan University, Faculty of Pharmacy
Country Saudi Arabia
Scopus ID 24921416100
Documents 53
Citations 1,992
h-index 22
Subject Area Drug Delivery Systems
Event International Top Pharmaceutical Awards
ORCID 0000-0003-2145-9956

Shamama Javed is a pharmaceutical researcher affiliated with the Faculty of Pharmacy at Jazan University, Saudi Arabia. Her scholarly work encompasses pharmaceutics, advanced drug delivery, nanotechnology, pharmaceutical formulation, and therapeutic applications of bioactive compounds. Her research profile demonstrates contributions to pharmaceutical sciences through publications addressing formulation development, drug delivery strategies, and emerging biomedical applications. These research areas provide the academic context for her recognition under the Pharmaceutical Excellence Award. [1]

Abstract

Shamama Javed’s research profile reflects academic contributions to contemporary pharmaceutical sciences, particularly drug delivery systems and nanotechnology-based formulations. Her publications explore advanced pharmaceutical carriers, formulation optimization, therapeutic applications of natural compounds, and approaches to improving drug delivery. The documented scholarly record includes research articles and reviews published in international journals. Her research activities demonstrate an interdisciplinary approach connecting pharmaceutics, nanomedicine, and biomedical research. [2]

Keywords

Shamama Javed; Pharmaceutical Excellence Award; Drug Delivery Systems; Pharmaceutics; Nanotechnology; Nanomedicine; Pharmaceutical Formulation; Drug Delivery Research; Nanocarriers; Pharmaceutical Sciences.

Introduction

Pharmaceutical research plays an important role in developing innovative formulations, improving therapeutic delivery, and addressing challenges associated with drug solubility, stability, and bioavailability. Shamama Javed’s scholarly contributions address several of these research priorities through investigations into pharmaceutical carriers, nanostructured formulations, and drug delivery technologies. Her publication record provides evidence of sustained engagement with research topics relevant to pharmaceutical development and therapeutic innovation. [3]

Research Profile

According to her ORCID record, Dr. Javed is an Assistant Professor in Pharmaceutics at the Faculty of Pharmacy, Jazan University, Saudi Arabia. Her registered scholarly activities include publications covering pharmaceutical formulation, nanotechnology, pharmacological applications, and advanced drug delivery approaches. Her ORCID profile records 38 research works, while the supplied Scopus profile reports 53 documents, 1,992 citations, and an h-index of 22. [1] [2]

Research Contributions

Her research contributions encompass the development and evaluation of nanostructured lipid carriers, nanoemulgels, cubosomes, and other pharmaceutical delivery platforms. Her collaborative publication on therapeutic deep eutectic systems examines their pharmaceutical applications in maximizing drug delivery. Additional research addresses specialized formulations and nanotechnology-based approaches relevant to therapeutic development. These subjects demonstrate the breadth of her research engagement in contemporary pharmaceutics. [4] [5]

Publications

Selected publications associated with Javed include Pharmaceutical Applications of Therapeutic Deep Eutectic Systems (2024), Cubosomes in Drug Delivery (2023), Development of Berberine-Loaded Bigel (2024), Design-of-Experiments-Assisted Fabrication of Quercetin-Loaded Nanoemulgel (2022), and Chronicles of Nanoerythrosomes (2021). These works represent research interests spanning formulation science, nanomedicine, pharmaceutical carriers, and therapeutic delivery. Their publication details are accessible through the corresponding DOI records. [4] [5]

Research Impact

The supplied Scopus indicators of 1,992 citations and an h-index of 22 provide quantitative measures of the scholarly visibility of her indexed research. Her publications address pharmaceutical topics with potential relevance to formulation development, therapeutic delivery, and biomedical applications. The combination of research articles and review publications contributes to the academic discussion of emerging pharmaceutical technologies and interdisciplinary approaches. [2]

Award Suitability

Shamama Javed’s documented research activities align with the objectives of the Pharmaceutical Excellence Award presented through the International Top Pharmaceutical Awards. Her work in drug delivery systems, nanotechnology, pharmaceutical formulation, and therapeutic applications demonstrates subject-area relevance. Her indexed publications, documented research contributions, and citation indicators provide a scholarly basis for consideration under this recognition category. [5]

Conclusion

Shamama Javed represents an active contributor to pharmaceutical research, with documented academic work in pharmaceutics, advanced drug delivery, and nanomedicine. Her publication portfolio reflects engagement with contemporary formulation technologies and interdisciplinary therapeutic research. Her academic affiliation and indexed scholarly record establish a relevant foundation for recognition under the Pharmaceutical Excellence Award, acknowledging contributions to the continuing development of pharmaceutical sciences.

References

  1. Elsevier. (n.d.). Scopus author details: Shamama Javed, Author ID 24921416100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=24921416100
  2. Javed, S., et al. (2024). Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line. Nanomedicine. https://doi.org/10.1080/17435889.2024.2370759
  3. Javed, S., et al. (2024). Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery. Heliyon. https://doi.org/10.1016/j.heliyon.2024.e29783
  4. Sivadasan, D., Sultan, M. H., Alqahtani, S. S., & Javed, S. (2023). Cubosomes in drug delivery—A comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines. https://doi.org/10.3390/biomedicines11041114
  5. Chitkara, A., Mangla, B., Kumar, P., Javed, S., Ahsan, W., & Popli, H. (2022). Design-of-experiments (DoE)-assisted fabrication of quercetin-loaded nanoemulgel and its evaluation against human skin cancer cell lines. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14112517

Ubaldo Armato | Drug Delivery Systems | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Ubaldo Armato
University of Verona, Italy

Ubaldo Armato
Affiliation University of Verona
Country Italy
Scopus ID 16502026200
Documents 179
Citations 3,838
h-index 34
Subject Area Drug Delivery Systems
Event International Top Pharmaceutical Awards

The Innovative Research Award recognizes scholarly excellence and sustained contributions to pharmaceutical and biomedical sciences. Ubaldo Armato of the University of Verona has established a notable academic profile through multidisciplinary investigations involving cellular biology, pathology, and drug delivery systems. His publication record and citation impact demonstrate consistent engagement with internationally recognized scientific research activities.[1]

Abstract

This article summarizes the academic achievements of Ubaldo Armato in relation to the Innovative Research Award. The assessment considers publication productivity, citation influence, and scientific engagement within pharmaceutical and biomedical research domains. Particular attention is given to contributions associated with drug delivery systems, pathology, and translational biomedical sciences. The review highlights measurable scholarly indicators and research dissemination activities documented through recognized academic databases.[1]

Keywords

Innovative Research Award, Ubaldo Armato, Drug Delivery Systems, Biomedical Sciences, Pharmaceutical Research, Scopus Author Profile, Citation Impact, Research Excellence.

Introduction

Academic awards provide recognition for scientific advancement and sustained scholarly engagement. Researchers working across pharmaceutical and biomedical disciplines contribute significantly to the understanding of disease mechanisms, therapeutic innovation, and translational medicine. Within this context, Ubaldo Armato’s scholarly record reflects an established commitment to research dissemination and interdisciplinary collaboration. His academic profile aligns with the objectives commonly associated with international scientific recognition programs.[2]

Research Profile

Ubaldo Armato is affiliated with the University of Verona and has contributed to numerous peer-reviewed publications indexed within international databases. His scholarly activities encompass cellular pathology, neurobiology, oncology, and pharmaceutical sciences. The documented publication count, citation metrics, and h-index collectively indicate long-term participation in impactful scientific research. These indicators are frequently utilized in evaluating academic productivity and research visibility.[1]

Research Contributions

Research contributions associated with Armato’s work include investigations into cellular responses, disease progression mechanisms, and biomedical applications relevant to therapeutic development. His studies have supported scientific understanding in areas connected to pharmaceutical innovation and biological systems analysis. Collaborative publications have further expanded the reach of these findings within international research communities. Such contributions continue to inform future studies and interdisciplinary inquiry.[3]

Publications

The research portfolio includes journal articles, collaborative studies, reviews, and biomedical investigations published through recognized academic channels. Publications have addressed molecular mechanisms, pathology, therapeutic approaches, and broader pharmaceutical applications. Citation activity associated with these works reflects continuing scholarly engagement and relevance within scientific literature. Multiple outputs have contributed to ongoing discussions in biomedical and pharmaceutical research communities.[1]

Research Impact

Research impact may be evaluated through citation frequency, interdisciplinary influence, and the continued use of published findings by subsequent investigators. With more than three thousand citations and a substantial h-index, Armato’s work demonstrates measurable visibility within academic literature. These metrics indicate that published studies have contributed to ongoing scientific dialogue and knowledge development. Research impact remains an important consideration in international award evaluations.[3]

Award Suitability

The Innovative Research Award emphasizes scholarly excellence, innovation, and meaningful contributions to scientific advancement. Based on publicly available academic indicators, publication records, and citation performance, Ubaldo Armato presents a profile consistent with the objectives of international research recognition initiatives. His multidisciplinary work and documented research productivity support consideration within competitive academic award frameworks. Evaluation remains subject to the criteria established by the awarding organization.[1]

Conclusion

Ubaldo Armato’s academic record reflects sustained participation in biomedical and pharmaceutical research. Publication activity, citation influence, and interdisciplinary engagement demonstrate a measurable contribution to scientific knowledge. These characteristics align with the broader objectives of recognizing impactful scholarship and innovation. The Innovative Research Award provides a framework through which such achievements may be formally acknowledged within the international scientific community.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Ubaldo Armato, Author ID 16502026200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=16502026200
  2. Jiang, L., Yang, S., Zhang, F., … De Santis, D., & Li, H. Cell-Free Adipose Liquid Extract Combined with Vascularized Lymph Node Transfer for Treating Lymphedema: Implications for Human Therapy.
    https://pubmed.ncbi.nlm.nih.gov/42479418/
  3. Chiarini, A.M., Armato, U., Gui, L., … Chang, S., & Dal Prà, I. Early divergent modulation of NLRP2′s and NLRP3′s inflammasome sensors vs. AIM2′s one by signals from Aβ·Calcium-sensing receptor complexes in human astrocytes.
    https://pubmed.ncbi.nlm.nih.gov/39426463/

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Published on by Top Pharmaceutical

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications 🏥. She has presented at international conferences and published extensively in high-impact journals 📚. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents ⚗️. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi 🎓 is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi 🔬 is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi 🔬 combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents 🦠🎗️. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation 🚀. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives 🏆. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi 🔬 is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications 🏥🏭, positioning her at the forefront of antibacterial and anticancer material research 🎗️. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents 📜, showcases a multidisciplinary methodology, blending computational modeling with experimental validation 💻⚗️. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments 🚀.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases 🏥. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏵️, Human Papillomavirus (HPV) 🎗️, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers 🧪 in various infections. Her contributions in genetic polymorphisms 🔬, cytokine responses 🌡️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.

Publication Top Notes

Investigation of oxidative stress in patient with Varicella Zoster Virus (VZV) infection

Human genetic variation susceptibility associated with HBV: analysis of genetic markers susceptibility to hepatitis b among patients in babylon province

Genetic study of TORCH infections in women with bad obstetric history: multiplex polymerase chain reaction for detection of common pathogens and agents of congenital infections

Evaluation of CD4 and CD8 in Patients Infected with Genital Wart Caused by Human Papilloma Virus in Babylon Province/Iraq

Evaluation of serum IgE, TNF alpha at patients with genital warts, Iraq.

Immunological Study for Patient with Verruca Vulgaris and Verruca Plana Caused by HPV in Hilla/Iraq

The effect of manganese poisoning on the histological structure of testis in male Swiss mice

Bacteriological Study of Tonsillitis Patients and Estimation of Concentrations of Certain Immunological Parameters.

The distribution of antimicrobial resistance and the presence of virulence genes in Escherichia coli isolated from frozen chicken meat in Iraq

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Published on by Top Pharmaceutical

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Assist. Prof. Dr. Nibras Mohammed Sahi, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nebras Mohammed Sahi 🦋, an Assistant Professor at the University of Babylon, specializes in entomology and plant extracts 🌿. Her research explores insect-derived products and medicinal plant applications in anticancer and antibacterial treatments 🧪. She has contributed to high-impact journals 📄 indexed in SCI and Scopus. Dr. Sahi prepared the propolis and Alhagi maurorum extract used in her latest research. Her work advances medicine, agriculture, and sustainability 🌍. With a citation index of 3, she actively collaborates on innovative biological studies. 💡🔬

Publication Profile

orcid

Professional Background

Dr. Nibras Mohammed Sahi 🦋, an Assistant Professor, specializes in entomology and plant extracts, focusing on the study of insects and their beneficial products. Her research explores the diverse applications of insect-derived compounds in medicine 💊, agriculture 🌱, and sustainability 🌍. Through collaborations with universities and research institutions, she investigates innovative ways to harness the potential of insects for ecological and economic benefits. Driven by a passion for scientific discovery 🔬, Dr. Sahi’s work contributes to advancements in bio-based solutions, aiming to enhance environmental conservation and agricultural productivity while promoting sustainable development.

Ongoing Research

Dr. Nibras Mohammed Sahi 🦋 is actively engaged in research on insect-derived products and plant extracts, with a particular focus on propolis 🐝 and Alhagi maurorum 🌿 for cancer 🧬 and antibacterial 🦠 applications. Her studies explore the therapeutic potential of these natural compounds, aiming to develop innovative solutions in medicine 💊 and biotechnology. While her work aligns with prestigious award categories, highlighting specific project funding 💰, collaborations 🤝, or research grants would further strengthen her academic profile. Through her dedication to scientific discovery 🔬, Dr. Sahi contributes to advancements in natural product research and sustainable healthcare solutions.

Professional Memberships

Dr. Nibras Mohammed Sahi 🦋 has not listed any editorial appointments, active collaborations, or professional memberships. However, participation in scientific societies 🏛️, international conferences 🎤, or editorial boards 📑 would significantly enhance her academic profile. Engaging in peer-reviewed journals 📚, contributing to scientific committees 🏅, or collaborating on global research initiatives 🌍 would further establish her influence in the field of entomology and natural product research. Highlighting such professional engagements would strengthen her candidacy, showcasing her dedication to advancing scientific knowledge 🔬 and fostering collaborations that drive innovation in medicine 💊, agriculture 🌱, and sustainability 🌿.

Research Focus

Assist. Prof. Dr. Nibras Mohammed Sahi’s research primarily focuses on microbiology 🦠, antibiotic resistance 💊, and bioactive compounds 🌱. His studies encompass pathogenic bacteria identification 🧫, antimicrobial activity testing 🧪, and molecular genetics 🧬 related to infectious diseases. He has extensively investigated natural plant extracts 🌿 and fungal metabolites 🍄 for their antibacterial and antifungal properties, along with genetic factors in diseases 🧑‍⚕️ like hepatitis B and colorectal cancer. His work also extends to insecticidal bioactive compounds 🪲 and their effects. His research contributes significantly to public health 🏥, pharmacology 💉, and molecular diagnostics 🔬.

Publication Top Notes

Molecular & Antibiotic Sensitivity Pattern Study of Acute Otitis Media, Tonsillitis & Periodontitis among Different Ages of Patients of Al-Hashmia General Hospital, Primary Care Centers & Private Clinic in Babylon Province

Analysis of Methanolic extract of Secondary Metabolites Released by Candida glabratus using GC-MS and Evaluation of Its Antimicrobial Activity

Detection of Bioactive Compounds of Raphanus sativus Using GC-MS and FT-IR Technical Analysis and Determination of its Anti-Bacterial and Anti-Fungal Activity.

Isolation and Identification of Some Pathogenic Bacteria from Otitis Media in Babylon Governorate

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Dr Shoaeb Mohammad Syed, Dayanand College of Pharmacy Latur, India

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India. With extensive experience in pharmaceutics, formulation development, and novel drug delivery systems, he mentors M.Pharm and Ph.D. students and guides research projects. He has two granted patents and authored several books and research publications. Dr. Syed is actively involved in curriculum development, research mentorship, and academic leadership. His work spans areas like drug delivery, nano drug systems, and quality control. He has also contributed to multiple national and international conferences. 🏫💊📚🔬📜💡🎓

Publication Profile

Google Scholar

Education

Dr. Shoaeb Mohammad Syed holds a PhD in Pharmacy from Govt. College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad (2014-2019). He completed his postgraduate studies in Pharmaceutics at Y B Chavan College of Pharmacy, Dr. BAMU Aurangabad, securing 74.45% (2010-2012). He earned his undergraduate degree in Pharmacy from the same institution with 69.79% (2007-2010). Additionally, he obtained a D. Pharmacy from MSBTE Mumbai, achieving 80.60% (2005-2007). Dr. Syed’s academic journey showcases his dedication and expertise in the field of pharmacy. 🎓💊📚

Experience

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India, where he leads research, supports faculty programs, and mentors PhD students. He contributes to curriculum development, research projects, and patent filing. Previously, he was an Assistant Professor at Dr. Vedprakash Patil Pharmacy College, developing publications and managing research proposals. His role as a Research Fellow at Govt. College of Pharmacy focused on formulation development and GMP. Dr. Syed has extensive teaching experience across multiple institutions, creating courses, mentoring students, and publishing research. 📚💡📝🔬🎓

Academic Leadership and Mentoring

Dr. Shoaeb Mohammad has demonstrated exemplary leadership in academia through his guidance of Ph.D. students, fostering a supportive environment for academic growth. His active involvement in research proposal development and grant management underscores his dedication to driving innovative research. Dr. Mohammad’s commitment to academic development is further highlighted by his efforts in organizing conferences and workshops, which contribute to the exchange of knowledge and collaboration within the academic community. His work not only supports the academic growth of individuals but also strengthens the overall academic environment, making a lasting impact on the field. 🌍🎤📚

Professional Impact

Dr. Shoaeb Mohammad, known for his expertise in pharmaceutical sciences, has made significant contributions both in academia and the pharmaceutical industry. With a strong presence in scientific writing, he excels in drafting patents and reviewing manuscripts for various journals, ensuring the advancement of pharmaceutical research. His work spans national and international platforms, influencing the development of the field. Dr. Shoaeb’s commitment to innovation and quality in scientific publishing is evident in his dedication to enhancing the global pharmaceutical landscape. His diverse skills and impact continue to shape the future of pharmaceutical sciences. 🏭📑🌍

Research Focus

Dr. Shoaeb Mohammad Syed’s research focus revolves around the development and evaluation of advanced drug delivery systems. His work emphasizes osmotic drug delivery, gastroretentive systems, and transdermal delivery using novel carriers like ethosomes. He has contributed significantly to the analytical validation of pharmaceutical methods, such as UV spectrophotometry and RP-HPLC for drug estimation. His studies also include controlled-release formulations, such as osmotic tablets for sustained drug release, and the application of microsponges in topical drug delivery. Dr. Syed’s expertise in pharmaceutical formulations and analytical techniques aims to enhance drug bioavailability and therapeutic efficacy. 🧪💊📊

Achievements

Dr. Shoaeb Mohammad is a highly accomplished professional with a strong academic background. He qualified GPAT in 2010, was awarded the AICTE scholarship for his post-graduation, and excelled in the NIPERJEE 2010. He received the UGC-MANF fellowship for his PhD and emerged as the winner of Avishkar Research Convention 2019 at Dr. BAMU, Aurangabad, and was selected for the State Level Avishkar 2020 at the University of Mumbai. Dr. Mohammad developed the MDR Shifa Oil (Pain Relief Liniment), which was approved by the FDA Maharashtra, India. 🏆🎓💊👨‍🔬

Publication Top Notes

Osmotic Drug Delivery System: An Overview.

AN OVERVIEW OF GASTRORETENTIVE DRUG DELIVERY SYSTEM RESEARCH

Transdermal delivery of ethosomes as a novel vesicular carrier for paroxetine hydrochloride: In vitro evaluation and In vivo study

Validation of UV Spectrophotometric Method For Determination of Atenolol

Analytical Method Development and validation of RP-HPLC Method for Determination of Eletriptan HBr.

Controlled Porosity Osmotic Tablet of Atenolol: In-Vitro and In-Vivo Evaluation

Quality by Design: An Approach for Formulation Development

 

 

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy